Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The future of dry powder inhaled therapy: Promising or discouraging for systemic disorders?
Yuqing Ye, Ying Ma, Jesse Zhu
International Journal of Pharmaceutics (2022) Vol. 614, pp. 121457-121457
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Application of PLGA as a Biodegradable and Biocompatible Polymer for Pulmonary Delivery of Drugs
Riya Mahar, Arpita Chakraborty, Nidhi Nainwal, et al.
AAPS PharmSciTech (2023) Vol. 24, Iss. 1
Closed Access | Times Cited: 40
Particle engineering in dry powders for inhalation
Regina Scherließ, Simon Bock, Nicholas Bungert, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 172, pp. 106158-106158
Open Access | Times Cited: 66
Liposomes or Extracellular Vesicles: A Comprehensive Comparison of Both Lipid Bilayer Vesicles for Pulmonary Drug Delivery
Ali Al-Jipouri, Samah Hamed Almurisi, Khater AL-Japairai, et al.
Polymers (2023) Vol. 15, Iss. 2, pp. 318-318
Open Access | Times Cited: 29
Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies
Sachin S. Gaikwad, Snehal R. Pathare, Mayur A. More, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 292-311
Closed Access | Times Cited: 28
Antioxidant Biodegradable Covalent Cyclodextrin Frameworks as Particulate Carriers for Inhalation Therapy against Acute Lung Injury
Siyu He, Li Wu, Hongyu Sun, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 34, pp. 38421-38435
Closed Access | Times Cited: 34
Recent advances in respiratory immunization: A focus on COVID-19 vaccines
Xiyue He, Xiaohong Chen, Hairui Wang, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 655-674
Open Access | Times Cited: 21
Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice
Haobo Weng, Weijuan Zou, Fangyan Tian, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Inhaled dry powder liposomal azithromycin for treatment of chronic lower respiratory tract infection
Yahya H. Dallal Bashi, Ahlam Ali, Yuosef Al Ayoub, et al.
International Journal of Pharmaceutics (2024) Vol. 653, pp. 123841-123841
Open Access | Times Cited: 5
The (re)emergence of aerosol delivery: Treatment of pulmonary diseases and its clinical challenges
Rosy Ghanem, Raphaëlle Youf, Tanguy Haute, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 421-439
Open Access
Cannabidiol and Hydroxypropyl-β-Cyclodextrin for the Development of Deflated Spherical-Shaped Inhalable Powder
Bruno Gomes, Laure-Anne Bya, Nathan Koch, et al.
The AAPS Journal (2025) Vol. 27, Iss. 1
Closed Access
Optimizing Andrographolide from Sambiloto Leaves (Andrographis paniculata) Using Cyclodextrin Metal–Organic Frameworks for Targeted Pulmonary Delivery via a Metered Dose Inhaler: A Proof-Of-Concept Study
Muhammad Ammar Syauqi, Andi Iqbal Burhanuddin, Azzahra Putri Utami Muharam, et al.
Molecular Pharmaceutics (2025)
Closed Access
Inhaled dry powder of bedaquiline loaded nano-carrier for the treatment of multi-drug resistant tuberculosis
Priyank Patel, Rakeshkumar Parmar
Journal of Research in Pharmacy (2025) Vol. 29, Iss. 1, pp. 445-468
Open Access
A Review of Non-Invasive Drug Delivery through Respiratory Routes
Yongbo Zhang, Dong Xu, Lu Bai, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1974-1974
Open Access | Times Cited: 26
Drug combinations for inhalation: Current products and future development addressing disease control and patient compliance
Heba Banat, Rita Ambrus, Ildikó Csóka
International Journal of Pharmaceutics (2023) Vol. 643, pp. 123070-123070
Closed Access | Times Cited: 14
The potential role of nanobodies in asthma therapy
Baraa Khalid Salah Al-Sheakly, Fatemeh Saheb Sharif‐Askari, Narjes Saheb Sharif‐Askari, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Stabilized Extracellular Vesicle Formulations for Inhalable Dry Powder Development
Evalyne M. Jansen, Luke van der Koog, Robin A.B. Elferink, et al.
Small (2025)
Open Access
Advanced Manufacturing Methods for High-Dose Inhalable Powders
Haia A. Al-Assaf, Sofia A. Papadimitriou, Ayesha Rahman, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 359-359
Open Access
Dry powder inhalers of antitubercular drugs
Nidhi Nainwal, Yuwanshi Sharma, Vikash Jakhmola
Tuberculosis (2022) Vol. 135, pp. 102228-102228
Closed Access | Times Cited: 21
The effect of exhalation before the inhalation of dry powder aerosol drugs on the breathing parameters, emitted doses and aerosol size distributions
Árpád Farkas, Gábor Tomisa, Szilvia Kugler, et al.
International Journal of Pharmaceutics X (2023) Vol. 5, pp. 100167-100167
Open Access | Times Cited: 9
A review on applications of fine particles integrated with fluidization technologies
Song Yue, Yue Yuan, Jesse Zhu
The Canadian Journal of Chemical Engineering (2024)
Open Access | Times Cited: 3
Pharmaceutical dry powders of small molecules prepared by thin-film freezing and their applications – A focus on the physical and aerosol properties of the powders
Tuangrat Praphawatvet, Zhengrong Cui, Robert O. Williams
International Journal of Pharmaceutics (2022) Vol. 629, pp. 122357-122357
Closed Access | Times Cited: 15
The influence of carrier type, physical characteristics, and blending techniques on the performance of dry powder inhalers
Riya Mahar, Arpita Chakraborty, Nidhi Nainwal
Journal of Drug Delivery Science and Technology (2022) Vol. 76, pp. 103759-103759
Closed Access | Times Cited: 14
Role of dispersion enhancer selection in the development of novel tratinterol hydrochloride dry powder inhalation formulations
Tingting Liu, Shiqing Tong, Qianqian Liao, et al.
International Journal of Pharmaceutics (2023) Vol. 635, pp. 122702-122702
Open Access | Times Cited: 8
Improving flow and fluidization quality of fine and ultrafine particles via nanoparticle modulation
Jiaying Wang, Yuanyuan Shao, Jesse Zhu
Nano Research (2023) Vol. 16, Iss. 10, pp. 12013-12025
Closed Access | Times Cited: 8
Enhancement of inhaled micronized powder flow properties for accurate capsules filling
Eva Gresse, Justine Rousseau, Myriam Akdim, et al.
Powder Technology (2024) Vol. 437, pp. 119576-119576
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top